New Crohns Indication Puts Janssens Stelara On Equal Ground With AntiTNFs

J&Js Janssen Biotech subsidiary won FDA approval for the IL12IL23 inhibitor Stelara to treat Crohns disease giving it a secondline...&160;&160;